• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presidio Investors Welcomes Javier Saade as New Operating Partner

    9/6/23 8:00:00 AM ET
    $ABT
    $BAH
    $DOCU
    $PRCH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Professional Services
    Consumer Discretionary
    Get the next $ABT alert in real time by email

    Presidio Investors, a leading middle market private equity firm that capitalizes technology, media, and financial services businesses, is pleased to announce that Javier Saade has joined the firm as Operating Partner. Along with Mark Goldman and Scott Bolick, Javier's unique perspective and expertise will further enhance the firm's strategic investment capabilities and create value across the portfolio. He is a principled leader that has over three decades of broad experience as an investor, board member, founder, operating executive, and former policymaker.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230906464989/en/

    Javier Saade (Photo: Business Wire)

    Javier Saade (Photo: Business Wire)

    Karl Schade, Managing Partner, said, "We are thrilled to welcome Javier to our team as our newest operating partner. With an exceptional background in strategy, policy, and operations, he brings a wealth of expertise that will undoubtedly elevate our firm's capabilities. We are excited to collaborate with Javier as we continue to navigate the dynamic landscape of our industry, driving innovation and delivering unparalleled value to our clients."

    Javier recently served as Audit Committee Chair of the Board of SoftBank Vision Fund Investment Corp. (NASDAQ:SVFA), Lead Independent Director of Porch Group, Inc. (NASDAQ:PRCH), Member of the Boards of Advisors of DocuSign, Inc. (NASDAQ:DOCU) and Univision Communications, and Member of the Boards of Trustees of The Nature Conservancy and Pan American Development Foundation. Earlier in his career, he held leadership, operational and investing roles at McKinsey & Company, Booz Allen & Hamilton (NYSE:BAH), Bridgewater Associates (a hedge fund with $160 billion in assets), Paradigm Ventures, Abbott Laboratories (NYSE:ABT), and Air America, a media company he co-founded. He also held a position of public trust as Associate Administrator, Chief of Investment and Innovation of the U.S. Small Business Administration (SBA) leading programs that have invested $120 billion in over 300,000 high growth companies and cutting-edge technologies. In addition, Javier concurrently served on the Committee for Small & Emerging Companies of the U.S. Securities & Exchange Commission (SEC), subsequently served on the Presidential Transition at the Department of Treasury, and currently serves on the Advisory Committee on Trade Policy & Negotiations at the White House.

    "I've known the Managing Partners of Presidio for decades and joining forces with them made all the sense in the world. The entire team's focus on enhancing company operations, driving growth, and creating value is notable and I look forward to helping the firm and its portfolio companies reach their potential," said Javier about joining Presidio.

    Currently he is Chairman of the Board of GP Funding, Inc., a Presidio portfolio company and leading specialty finance company focused on the legal and healthcare sectors. He is also Managing Partner of Impact Master Holdings, Venture Partner at Fenway Summer, Contributor at CNBC, and Executive Fellow at Harvard Business School.

    About Presidio Investors

    Presidio Investors is a leading Austin, Texas-based private equity firm investing in quality businesses in the lower middle market. With a proven history of successful investments, the firm partners with exceptional management teams to create long-term value and achieve superior financial results. Presidio Investors is committed to identifying and capitalizing on compelling investment opportunities that offer significant growth potential. For more information, please visit www.presidioinvestors.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230906464989/en/

    Get the next $ABT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABT
    $BAH
    $DOCU
    $PRCH

    CompanyDatePrice TargetRatingAnalyst
    DocuSign Inc.
    $DOCU
    2/23/2026$45.00Buy → Hold
    Jefferies
    Porch Group Inc.
    $PRCH
    2/11/2026$10.50Mkt Perform → Outperform
    Keefe Bruyette
    DocuSign Inc.
    $DOCU
    12/17/2025$88.00Buy
    BTIG Research
    Booz Allen Hamilton Holding Corporation
    $BAH
    12/12/2025$93.00Neutral
    Citigroup
    Booz Allen Hamilton Holding Corporation
    $BAH
    10/24/2025$90.00Buy → Underperform
    BofA Securities
    Booz Allen Hamilton Holding Corporation
    $BAH
    10/17/2025$105.00Buy → Hold
    TD Cowen
    Abbott Laboratories
    $ABT
    10/10/2025$145.00Buy
    The Benchmark Company
    Porch Group Inc.
    $PRCH
    9/2/2025$21.00Buy
    Goldman
    More analyst ratings

    $ABT
    $BAH
    $DOCU
    $PRCH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Docusign Announces Timing of Fourth Quarter Fiscal 2026 Earnings Conference Call

    SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- Docusign (NASDAQ:DOCU) today announced that its fourth quarter fiscal 2026 results will be released on Tuesday, March 17, 2026, after the close of the market. The company will host a conference call at 2:00 p.m. Pacific Daylight Time (5:00 p.m. Eastern Daylight Time) to discuss its financial results. A live webcast of the event will be available on the Docusign Investor Relations website at investor.docusign.com. A live dial-in will be available domestically at 877-407-0784 or internationally at 201-689-8560. A replay will be available domestically at 844-512-2921 or internationally at 412-317-6671 until midnight (EDT) March 31, 2026, using the pa

    2/24/26 4:05:00 PM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology

    Docusign Partners with Anthropic to Bring Its Intelligent Contract Workflows to Cowork

    SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- Docusign (NASDAQ:DOCU), the leader in AI-powered contract management, today announced that its Intelligent Agreement Management (IAM) platform is available as part of Anthropic's Cowork. By connecting to Docusign in Cowork, businesses can securely create, review, send, and manage agreements from start to finish — all through natural language prompts in Cowork. This integration transforms how teams work with agreements, moving from passive summarization to active execution like drafting agreements, routing them for review, and triggeri

    2/24/26 9:30:00 AM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology

    Exact Sciences Stockholders Approve Acquisition by Abbott

    Exact Sciences Corporation (NASDAQ:EXAS) ("Exact Sciences"), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the proposed acquisition of Exact Sciences by Abbott (NYSE:ABT) at the special meeting of stockholders held earlier today. At the special meeting, preliminary results showed that more than 99% of the votes cast, representing approximately 67% of the total outstanding shares of Exact Sciences common stock as of the January 9, 2026 record date for the special meeting, were voted in favor of the transaction. Final voting results from the special meeting will be reported by Exact Sciences in a Current Report on Form 8‑

    2/20/26 4:05:00 PM ET
    $ABT
    $EXAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities

    $ABT
    $BAH
    $DOCU
    $PRCH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DocuSign downgraded by Jefferies with a new price target

    Jefferies downgraded DocuSign from Buy to Hold and set a new price target of $45.00

    2/23/26 8:31:21 AM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology

    Porch Group upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Porch Group from Mkt Perform to Outperform and set a new price target of $10.50

    2/11/26 7:42:24 AM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    BTIG Research initiated coverage on DocuSign with a new price target

    BTIG Research initiated coverage of DocuSign with a rating of Buy and set a new price target of $88.00

    12/17/25 9:18:48 AM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology

    $ABT
    $BAH
    $DOCU
    $PRCH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Starks Daniel J bought $1,087,331 worth of Common shares without par value (10,000 units at $108.73), increasing direct ownership by 0.15% to 6,738,817 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    2/6/26 8:04:16 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VP, PAO & Controller Metzfield Dennis covered exercise/tax liability with 229 shares, decreasing direct ownership by 5% to 4,340 units (SEC Form 4)

    4 - Booz Allen Hamilton Holding Corp (0001443646) (Issuer)

    2/4/26 4:30:00 PM ET
    $BAH
    Professional Services
    Consumer Discretionary

    CHAIRMAN AND CEO Ford Robert B bought $2,013,967 worth of Common shares without par value (18,800 units at $107.13) (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    1/26/26 8:02:24 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $BAH
    $DOCU
    $PRCH
    SEC Filings

    View All

    SEC Form 424B5 filed by Abbott Laboratories

    424B5 - ABBOTT LABORATORIES (0000001800) (Filer)

    2/25/26 7:01:49 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Abbott Laboratories

    424B3 - ABBOTT LABORATORIES (0000001800) (Filer)

    2/23/26 9:31:03 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-3ASR filed by Abbott Laboratories

    S-3ASR - ABBOTT LABORATORIES (0000001800) (Filer)

    2/23/26 8:55:31 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $BAH
    $DOCU
    $PRCH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 24, 2023 - FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes

    For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. This is the first targeted therapy approved for this indication. The agency also approved the Abbott RealTime

    10/24/23 3:52:17 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $BAH
    $DOCU
    $PRCH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Starks Daniel J bought $1,087,331 worth of Common shares without par value (10,000 units at $108.73), increasing direct ownership by 0.15% to 6,738,817 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    2/6/26 8:04:16 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CHAIRMAN AND CEO Ford Robert B bought $2,013,967 worth of Common shares without par value (18,800 units at $107.13) (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    1/26/26 8:02:24 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Rozanski Horacio bought $2,014,908 worth of shares (23,800 units at $84.66), increasing direct ownership by 4% to 687,745 units (SEC Form 4)

    4 - Booz Allen Hamilton Holding Corp (0001443646) (Issuer)

    10/30/25 8:39:06 PM ET
    $BAH
    Professional Services
    Consumer Discretionary

    $ABT
    $BAH
    $DOCU
    $PRCH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Porch Group Inc.

    SC 13G/A - Porch Group, Inc. (0001784535) (Subject)

    11/14/24 4:17:30 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Booz Allen Hamilton Holding Corporation

    SC 13G/A - Booz Allen Hamilton Holding Corp (0001443646) (Subject)

    11/14/24 1:22:34 PM ET
    $BAH
    Professional Services
    Consumer Discretionary

    SEC Form SC 13G/A filed by Porch Group Inc. (Amendment)

    SC 13G/A - Porch Group, Inc. (0001784535) (Subject)

    2/14/24 11:24:46 AM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    $ABT
    $BAH
    $DOCU
    $PRCH
    Leadership Updates

    Live Leadership Updates

    View All

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    Pipedrive Appoints Regi Vengalil as CFO to Drive Next Stage of AI-Native Growth

    Pipedrive, the easy and effective sales CRM for small companies, today announced the appointment of Regi Vengalil as the company's new Chief Financial Officer. Vengalil brings nearly two decades of financial and strategic leadership experience from high-growth SaaS, fintech, and AI-driven companies, guiding companies through complex market landscapes and driving clarity and discipline in financial operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202982724/en/Pipedrive appoints Regi Vengalil as CFO to drive next stage of AI-native growth Vengalil joins Pipedrive from Trax Retail, a leader in AI image recognition softw

    12/2/25 7:00:00 AM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    SHARON AI To Appoint Mr Drew Kelton To Board of Directors

    SHARON AI, Inc. ("SHARON AI"), Australia's leading Neocloud, is pleased to announce that highly experienced global technology executive Mr Drew Kelton has agreed to join the Sharon AI Holdings Inc board of directors. Mr Kelton is a global business leader and professional board director. With 40 years' experience in the information and communications technology arena, he has held senior roles in the UK, Europe, India, Australasia and the US. "SHARON AI is building the next generation of sovereign AI and digital infrastructure, and I'm excited to be part of a company with both the vision and capability to lead this transformation," said Drew Kelton. Mr Kelton was previously Chief Executive

    12/1/25 3:06:00 PM ET
    $DOCU
    $TMUS
    Computer Software: Prepackaged Software
    Technology
    Telecommunications Equipment
    Telecommunications

    $ABT
    $BAH
    $DOCU
    $PRCH
    Financials

    Live finance-specific insights

    View All

    Docusign Announces Timing of Fourth Quarter Fiscal 2026 Earnings Conference Call

    SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- Docusign (NASDAQ:DOCU) today announced that its fourth quarter fiscal 2026 results will be released on Tuesday, March 17, 2026, after the close of the market. The company will host a conference call at 2:00 p.m. Pacific Daylight Time (5:00 p.m. Eastern Daylight Time) to discuss its financial results. A live webcast of the event will be available on the Docusign Investor Relations website at investor.docusign.com. A live dial-in will be available domestically at 877-407-0784 or internationally at 201-689-8560. A replay will be available domestically at 844-512-2921 or internationally at 412-317-6671 until midnight (EDT) March 31, 2026, using the pa

    2/24/26 4:05:00 PM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology

    Abbott declares 409th consecutive quarterly dividend

    ABBOTT PARK, Ill., Feb. 20, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share. This marks the 409th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable May 15, 2026, to shareholders of record at the close of business on April 15, 2026.Abbott has increased its dividend payout for 54 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio o

    2/20/26 11:38:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Porch Group Reports Fourth Quarter 2025 Results

    Strong Q4 Performance Caps Off a Successful First Year Under Reciprocal Model Porch Group, Inc. ("Porch," "the Company," "we," "our," "us") (NASDAQ:PRCH), a new kind of homeowners insurance company, today reported fourth quarter and full-year results through December 31, 2025, that exceeded our expectations. Porch generated for shareholders1 fourth quarter 2025 revenue of $112.3 million. Net loss attributable to Porch was $(3.5) million, and Adjusted EBITDA was $23.5 million. In January 2025, the Porch Reciprocal Exchange ("Reciprocal") was formed as an insurance entity owned by its policyholder-members and not by Porch. While Porch does not own the Reciprocal, it is consolidated for

    2/11/26 4:02:00 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology